Home | Sitemap | Search | Contact A- A A+
   
 
    Public Member Support us  
 

IBCSG 26-02 / BIG 4-02 (PERCHE) 

A phase III trial evaluating the role of chemotherapy as adjuvant therapy for premenopausal women with endocrine responsive breast cancer who receive endocrine therapy

Premenopausal Endocrine Responsive Chemotherapy Trial (PERCHE)

DESIGN

please click on the picture to see a larger version

Results & Publications


Posters


Presentations

Study Chairs
BIG: Dr. Rosalba Torrisi - Milano, Italy
US Intergroup: Dr. Edith A. Perez - Jacksonvill, USA

Statistician
Dr. Meredith Regan

Trial Coordinators
Karolyn Scott, Jocelyn Swick, Chris Rickard, Tara Scolese
IBCSG Data Management Center/FSTRF 4033 Maple Road
Amherst, New York 14226 USA
Phone: +1 716 834 0900
Fax: +1 716 836 6097
Email: ibcsg24-26_STP@fstrf.org

Date of Activation
August 4, 2003

Targeted Accrual
1750 patients


Results Publications Results & Publications
Other Pathology


News

11.12.2008:
BIG 1-98: Results from sequential treatment analysis and updated monotherapy analysis

11.12.2008:
Brinker Award for Richard Gelber and Aron Goldhirsch

11.12.2008:
All presentations from investigators' meetings at San Antonio Breast Cancer Symposium now

All News

 
  Print